Acasti Pharma Inc. , a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre.
Acasti Pharma stock last closed at $1.77, down 5.65% from the previous day, and has decreased 52.42% in one year. It has underperformed other stocks in the Biotechnology industry by 0.2 percentage points. Acasti Pharma stock is currently +2.91% from its 52-week low of $1.72, and -64.94% from its 52-week high of $5.05.
As of Sep 22, 2023, there are 7.45M shares of ACST outstanding. The market capitalization of ACST is $13.18M. In the last 24 hours, 30,575 ACST shares were traded.
You will need a brokerage account to access the NASDAQ market and buy ACST stock.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by opening an account with eToro today.Open eToro Account
Now that you've selected your brokerage, you need to fill out some personal details so you are able to buy ACST today.
Now that you've filled out your info on the best stock app to use, your next step is to transfer the money for your investment:
Check out this video walkthrough for more details transferring funds into your new brokerage account.
After you have selected the best place to buy Acasti Pharma stock, it's important to research their stock prior to investing, so you can understand the risk as well as the opportunity.
WallStreetZen was created to help average investors do better fundamental analysis in less time.
You can see all of the due diligence checks on ACST's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge ACST's true value.
Using relative valuations ratios:
You can do more valuation analysis on ACST's stock here.
You can dig deeper into what analysts are forecasting on the Acasti Pharma stock forecast page.
Last year, ACST revenue was $0.00. During the last 2 year, ACST's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 108.03%.
Find out more about ACST's earnings and revenue performance here.
Over the past 12 months, insiders at ACST have bought more shares than they have sold.
Donald Olds, Director of ACST, was the latest ACST insider to buy. They bought $781.05 worth of ACST shares on Aug 31, 2023.
Get more info about who owns ACST stock here.
No, Acasti Pharma doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two primary options:
Press the Open button and your broker will execute your order.
If you need more help buying stocks on eToro, watch the helpful video below:
Now that you own some shares in ACST, you'll want to keep up with your company.
Add ACST to a watchlist to get alerted to the latest events about your ACST stock.
To summarize, here are the 6 steps for buying Acasti Pharma stock:
If you are looking for a place to buy stocks, eToro is our recommended venue.Get Started with eToro Today
If you would like to get updates on your investment in Acasti Pharma, hit the button below to create your watchlist.
How much does it cost to buy one Acasti Pharma share?
What is the best way to buy Acasti Pharma stock?